| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/26/2011 | EP2277861A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
| 01/26/2011 | EP2277858A1 Amide compound |
| 01/26/2011 | EP2277542A1 Modified antibodies to prostrate-specific membrane antigen and uses thereof |
| 01/26/2011 | EP2277526A1 Pharmaceutical composition with tetrahydroisohumulone |
| 01/26/2011 | EP2277520A2 A pharmaceutical composition for angiotensin ii-mediated diseases |
| 01/26/2011 | EP2277514A1 A method for chemoprevention of prostate cancer |
| 01/26/2011 | EP2277513A2 Treatment of incontinence with 5htc2 agonists |
| 01/26/2011 | EP2276756A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 01/26/2011 | EP2276732A1 Novel estrogen receptor ligands |
| 01/26/2011 | EP2089361B1 Inhibitors of sodium glucose co-transporter 2 and methods of their use |
| 01/26/2011 | EP1496892B1 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/26/2011 | CN1918128B Fused ring 4-oxopyrimidine derivative |
| 01/26/2011 | CN101959866A Novel 1-benzyl-3-hydroxymethyilindazole derivatives and use thereof in the treatment of diseases based on the expression MCP-1 and CX3CR1 |
| 01/26/2011 | CN101959511A Trpa1 antagonists |
| 01/26/2011 | CN101955871A Rice wine beverage for tonifying kidney and preparation method thereof |
| 01/26/2011 | CN101955505A Novel immune suppressor and composition thereof |
| 01/26/2011 | CN101954071A Use of ulinastatin in preparation of medicament for treating systemic lupus erythematosus and medicinal composition of ulinastatin |
| 01/26/2011 | CN101954068A Combined medicament for treating prostatitis and preparation method thereof |
| 01/26/2011 | CN101954037A Chinese medicinal preparation for treating prostatitis |
| 01/26/2011 | CN101954018A Oral medicament for treating chronic nephritis |
| 01/26/2011 | CN101954011A Chinese medicinal preparation for treating urethritis |
| 01/26/2011 | CN101953982A Traditional Chinese medicine plaster for treating chronic pyelonephritis |
| 01/26/2011 | CN101953981A Chinese medicinal preparation for treating stranguria caused by overstrain |
| 01/26/2011 | CN101953971A Nourishing wine |
| 01/26/2011 | CN101953970A Medicament for treating prostatitis |
| 01/26/2011 | CN101953965A Six-ingredient rehmannia soft capsules and preparation method thereof |
| 01/26/2011 | CN101953963A Traditional Chinese medicinal preparation for treating brain and renal function failure |
| 01/26/2011 | CN101953956A Traditional Chinese medicine for treating diabetic nephropathy |
| 01/26/2011 | CN101953953A Medicinal preparation for preventing and treating prostatic hypertrophy and preparation method thereof |
| 01/26/2011 | CN101953940A Traditional Chinese medicine having function of tonifying kidney, invigorating blood circulation and relieving pain, preparation method and quality specification thereof |
| 01/26/2011 | CN101953937A Chinese medicament for treating chronic prostatitis |
| 01/26/2011 | CN101953920A Traditional Chinese medicine for treating prostatic hyperplasia |
| 01/26/2011 | CN101953899A Traditional Chinese medicinal composition for tonifying kidney and yang |
| 01/26/2011 | CN101953888A Side effect-free medicament for treating prostatic hyperplasia |
| 01/26/2011 | CN101953883A Chinese medicinal granules for treating calculosis and preparation method thereof |
| 01/26/2011 | CN101953496A Lithiasis recovery drinks |
| 01/26/2011 | CN101396506B Traditional Chinese medicine for treating chronic glomerulonephritis |
| 01/26/2011 | CN101380456B Traditional Chinese medicine for treating infantile bed-wetting |
| 01/26/2011 | CN101336682B Honey beverage and preparation method thereof |
| 01/26/2011 | CN101322773B Medicament for treating prostatic diseases |
| 01/25/2011 | US7875728 Hydrazonopyrazole derivatives and their use as therapeutics |
| 01/25/2011 | US7875712 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 01/25/2011 | CA2599158C Pharmaceutical agent comprising solifenacin |
| 01/25/2011 | CA2477557C Stabilized albumin preparations |
| 01/25/2011 | CA2468673C Compounds specific to adenosine a1 and a3 receptors and uses thereof |
| 01/25/2011 | CA2468180C Anti-proliferative composition |
| 01/25/2011 | CA2463146C Crystalline sodium salt of telmisartan and the use of same as an angiotensin antagonist |
| 01/25/2011 | CA2458690C Pharmaceutical compositions comprising an ascomycin derivative |
| 01/25/2011 | CA2447765C 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors |
| 01/25/2011 | CA2434299C Tricyclic androgen receptor modulator compounds and methods |
| 01/25/2011 | CA2432582C Sulfamidothienopyrimidines |
| 01/25/2011 | CA2384425C Methods and compositions for delivery of pharmaceutical agents |
| 01/25/2011 | CA2381882C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/25/2011 | CA2334200C Pyrrolo[2,3d]pyrimidine compositions and their use |
| 01/20/2011 | WO2011008543A2 Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal |
| 01/20/2011 | WO2011007882A1 Insulin-producing cell inducer, glucose intake enhancer, and therapeutic agent for diabetes or diabetes complications |
| 01/20/2011 | WO2011007722A1 3-substituted-2-furancarboxylic acid hydrazide derivative and pharmaceutically acceptable salt thereof |
| 01/20/2011 | WO2011007091A1 Derivatives of 5,6-bisaryl-2-pyridine-carboxamide, preparation thereof, and therapeutic use thereof as urotensin-ii receptor antagonists |
| 01/20/2011 | US20110015437 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 01/20/2011 | US20110015376 Papilloma Virus-Like Particles, Fusion Proteins as Well as Processes for Their Production |
| 01/20/2011 | US20110015235 Novel phenylethynyl derivatives of 8-aza-bicyclo[3.2.1]octane and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/20/2011 | US20110015230 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 01/20/2011 | US20110015211 Fibrosis inhibitor |
| 01/20/2011 | US20110015167 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels |
| 01/20/2011 | US20110015164 Method of treating men with metabolic and anthropometric disorders |
| 01/20/2011 | US20110015129 New paediatric indications for direct thrombin inhibitors |
| 01/20/2011 | US20110015127 Targeting complement factor h for treatment of diseases |
| 01/20/2011 | US20110014270 Prevention and treatment of ischemia-reperfusion injury and related conditions |
| 01/20/2011 | US20110014251 Microvesicles |
| 01/20/2011 | US20110014176 Compounds and method for reducing uric acid |
| 01/20/2011 | DE102009033396A1 Wässrige Lösung und gelatinierte Zusammensetzung umfassend einen Phosphodiesterase-5-Inhibitor sowie diesbezügliche Verfahren und Verwendung Aqueous solution and gelatinized composition comprising a phosphodiesterase-5 inhibitor, and related procedures and use |
| 01/19/2011 | EP2275557A1 Albumin fusion proteins |
| 01/19/2011 | EP2275420A1 Therapeutic agents useful for treating pain |
| 01/19/2011 | EP2275411A2 Reformatsky Reagent in Stable Form and Process for Producing the Same |
| 01/19/2011 | EP2275102A1 N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 01/19/2011 | EP2274296A1 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 01/19/2011 | EP2273976A2 Treatment of bladder dysfunction using liposomal botulinum toxin |
| 01/19/2011 | EP1799633B1 Crystalline forms of (-)-(1r,2r)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride for use as active ingredient in pharmaceutical compositions |
| 01/19/2011 | EP1773867B1 Proteinaceous compounds and uses therefor |
| 01/19/2011 | EP1481969B1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient |
| 01/19/2011 | EP1432416B1 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 01/19/2011 | CN1989855B Cordyceps sinensis cigarette and process for manufacturing same |
| 01/19/2011 | CN1950389B Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 01/19/2011 | CN101952280A Bicyclic heterocyclic derivative |
| 01/19/2011 | CN101952256A Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40 |
| 01/19/2011 | CN101952249A Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives |
| 01/19/2011 | CN101951933A Compositions for the treatment of benign prostate hypertrophy, prostatitis, prostatosis and prostate cancer |
| 01/19/2011 | CN101948539A IL-18 binding proteins |
| 01/19/2011 | CN101948506A Finasteride conjugate and application thereof to preparation of medicament for treating prostate |
| 01/19/2011 | CN101948464A 3,4,6-triaryl-(1,3)-oxazine-2-ketone compound as well as preparation method and application thereof |
| 01/19/2011 | CN101948416A Compound used for treating metabolic disorder |
| 01/19/2011 | CN101947306A Treatment of T-cell mediated diseases |
| 01/19/2011 | CN101947293A Medicament for treating urinary tract infection and preparation method thereof |
| 01/19/2011 | CN101947237A Externally-applied hypochlorous acid liquid with functions of oxidizing, disinfecting, expelling and removing toxins |
| 01/19/2011 | CN101623455B Medicine for treating prostate hyperplasia |
| 01/19/2011 | CN101559113B Chinese materia medica preparation for treating chronic renal insufficiency and preparation method thereof |
| 01/19/2011 | CN101342281B Medicine for treating prostatosis and method for preparing same |
| 01/19/2011 | CN101292685B Health care edible oil |
| 01/19/2011 | CN101284115B Kidney-tonifying and body-strengthening pellet |
| 01/19/2011 | CN101279010B Application of guilu erxian paste for preparing medicine for curing hyperplasia of prostate gland |